Article Details
Retrieved on: 2025-10-03 06:02:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Takis is actively advancing humanized monoclonal antibodies and bispecifics for oncology and infectious diseases, including COVID-19. The company ...
Article found on: www.prnewswire.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here